Alzheimer’s & Dementia

Filter Your Results

 

News

 

Seeking Breakthroughs: The Industry Perspective

September 2018—A roundtable discussion with Gregory Went, PhD, Adamas Pharmaceuticals; Lynn Kramer, MD, Eisai; Paulo Fontoura, MD, PhD, Genentech/Roche; Justin Gover, BSc, MBA, GW Pharmaceuticals; Marc Kamin, MD, SK Life Sciences; and Mike Davis, BSc, MBA, UCB

Seeking Breakthroughs—We Want You!

Shamik Bhattycharyya, MD, MS

September 2018—The challenges we must overcome to find breakthrough treatments in neurology are many and the potential is great.

Breakthrough Device Designation Granted for Digital and Adaptive Reminiscence Therapy

Wednesday, August 29, 2018—The Food and Drug Administration (FDA) has designated a digital therapy for persons with Alzheimer’s Disease (AD) as a breakthrough device. This designation, a provision…

Long-Term Safety and Efficacy of Valbenazine for Patients With Tardive Dyskinesia

Monday, August 20, 2018—Long-term results for valbenazine (Ingrezza; Neurocrine Biosciences, San Diego, CA), a treatment for patients with tardive dyskinesia (TD), are being presented at the 2018 Wor…

Funding Received for Phase 2 Trial of Xanomeline-Tropsium Chloride

Wednesday, August 08, 2018—A $42-million financing round has been completed and will be used to finance a phase 2 trial of xanomeline-tropsium chloride (KarXT; Karuna, Boston, MA) for treatment of perso…

Braintest App Has Equivalent Sensitivity and Specificity as SAGE Test for Mild Cognitive Impairment

Tuesday, August 07, 2018—There is an app (BrainTest, Columbus, OH) used to detect mild cognitive impairment (MCI). It is a clinically validated, digital version of the paper and pen Self-Administered …

Aggressive Treatment of Hypertension Promotes Healthy Brains and Hearts

Monday, July 30, 2018—Aggressive lowering of systolic blood pressure (BP) reduces the risk of mild cognitive impairment (MCI) and combined MCI and dementia. In the SPRINT trial (NCT01206062), 2 str…

Breaching the Blood-Brain Barrier: A Potential New Treatment Modality

Monday, July 30, 2018—In a small, yet groundbreaking, clinical trial, MR-guided focused ultrasound (MRgFUS) (ExablateNeuro; Insightec, Miami FL) was used to open the blood-brain barrier (BBB) safel…

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.

 
  • BRYN MAWR COMMUNICATIONS III, LLC